Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Intomics Enters €5.2M Personalized Cancer Diagnostic Project

Published: Thursday, June 06, 2013
Last Updated: Thursday, June 06, 2013
Bookmark and Share
Vejle Sygehus, DTU, Exiqon A/S, and Intomics A/S have joined forces.

The project will optimize treatment of cancer patients based on the cancers’ individual genetic fingerprint. Intomics will use its leading biomedical data analysis capabilities to help choose the right treatment from cancer-derived genetic information.

The project receives €3.0M in financial support from The Danish National Advanced Technology Foundation.

Two cancer patients may respond very differently to the same treatment if their genetic cancer fingerprints differ.

Mutations in genes participating in key cancer pathways and mechanisms may impact whether a given patient responds well to a treatment or not.

“By enhancing our understanding of the correlation between key mutations in cancer pathways and treatment outcome, we can better select the optimal treatment for each individual patient” says Thomas S. Jensen, CEO of Intomics A/S.

Vejle Sygehus, the Technical University of Denmark (DTU), Exiqon A/S, and Intomics A/S have joined forces to develop a future platform for precision medicine in a five-year project supported by The Danish National Advanced Technology Foundation.

The project will focus on colorectal cancer, where genetic information from many samples will be available.

Intomics A/S is developing sophisticated tools for analyzing and combining large quantities of biomedical data, including genetic variation data from individuals.

Based on these tools and Intomics’ unique expertise within molecular systems biology, genetic data derived from tumours will be analyzed and correlated with treatment outcome to advance the field of precision medicine.

Thomas S. Jensen continues, “We are very happy to be part of the project. I see a great synergy between the four partners and strongly believe that by teaming up with leading companies and research institutions in cancer research, data analysis, and diagnostic kit development, we can make important discoveries that can help cancer patients.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 4,000+ scientific posters on ePosters
  • More than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Cancer Genetics: Key to Diagnosis, Therapy
When applied judiciously, cancer genetics directs caregivers to the right drug at the right time, while sparing patients of unnecessary or harmful treatments.
New Mechanism to Control Human Viral Infections Discovered
Researchers discover long sought after mechanism in human cells that could help treat diseases caused by viruses.
Study Reveals New Role for Hippo Pathway in Suppressing Cancer Immunity
Hippo pathway signaling regulates organ size by moderating cell growth, apoptosis and stem cell renewal, but dysregulation contributes to cancer development.
RNAi Activated in Response to Influenza
Discovery could lead to better ways of combating serious infections, including Ebola and Zika.
Gene Therapy Maintains Clotting Factor for Hemophilia Patients
Following a single gene therapy dose, the highest levels of an essential blood clotting factor IX were observed in hemophilia B patients.
Transporting Microscopic Cargo Between Human Cells
Scientists have developed a virus-inspired delivery system for material transport between cells.
Improving Drug Production with Computer Model
A model has been developed that can be used to improve and accelerate the production of biotherapeutics, cancer drugs, and vaccines.
Turning Off Asthma Attacks
Researchers discover a critical cellular “off” switch for the inflammatory immune response that causes asthma attacks.
New Strategy May Drop Cancer’s Guard
Scientists eye ways to deconstruct tumors’ protective wall with current diabetes drug.
Scientists Identify Unique Genomic Features in Testicular Cancer
The findings may shed light on factors in other cancers that influence their sensitivity to chemotherapy.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!